康希诺生物：截至2024年12月31日止的年度业绩公告

CanSino Biologics Inc. 6185 20241231 20241231 20241231 (www.hkexnews.hk)(www.cansinotech.com)20241231 Xuefeng YU 2025325 Xuefeng YUShou Bai CHAO 0277 0478 0579 0780 2581 31163 50 69 72 202422320245302024627Xuefeng YU2024221 Xuefeng YUShou Bai CHAO2024221Dongxu QIU2024221 202422120242212024112520241125 2024221202453020246272024221 Xuefeng YU 202422120242212024221 (FCG HKFCGPE)) 2024223202422320242212024221 185401-420 2024223Xuefeng YU202422320242212024223Shou Bai CHAO20242232024221 33191901 H 183171712-1716 1526 77334 •8835 6185688185 www.cansinotech.com 2022®®2024793.841.3%®3-3473-683® 20252024 6II/III 98% VLP1900202412I/II ®18-55®Halal NIBMmRNA ButantanmRNA PQ Xuefeng YU博 士 3(i)®®®Ad5-EBOVPBPVDTcP-Hib-MCV4(ii)®®PCV13iDTcPTdcp(iii)CS-2606 mRNACS-2028CS-2023 • ®® ®MCV4® ®IIIMCV2®3623 20211220216®®®MCV4®MPSV4®3347® ®793.841.3% 202411MCV433473683MCV41859 202412MCV4MCV41855MCV420252MCV4(LPPOM MUI)MCV4 ®®®XBB.1.5 ®5SCOVID-19 ®®®®®®®®® 20212® 20229®®202312XBB.1.5XBB.1.5 Ad5-EBOV Ad5-EBOV50%201710Ad5-EBOVAd5-EBOVGMP Ad5-EBOV(i)2˚C8˚C12(ii)(iii) Ad5-EBOVAd5-EBOV PCV13i PCV13iPCV13PCV13i 20241PCV13iIIIPCV13i 20242PCV13i PCV13i2025PCV13i PBPV PBPV23(PPV23)13(PCV13)2390PBPVAPspAPBPVPPV23PCV13 20244PBPVIIaIbIaIbPBPVIPBPV DTcP DTcP(DTaP)DTcP DTcPTdcp 202412DTcPDTcPIIIIII 20252DTcP2025DTcP Tdcp Tdcp6TdcpTdcpBoostrixAdacel 202412TdcpII/III TdcpIII 20243III 202522026 Ad5Ag85AIaI Ib 2025I5 20237Barinthus BiotherapeuticsUK LimitedVaccitechUK LimitedShingrixShingrix 202311II I 202310••220241017 20241I 20241012I/II I/II DTcP-Hib-MCV4 DTcP-Hib-MCV4MCV4®DTcPIIIHibIDTcP-Hib-MCV4 DTcP-Hib-MCV4 mRNA mRNA mRNA mRNACMCChemistry, Manufacturing and Controls)mRNAmRNA 20247(NIBM)mRNAmRNA ®®mRNAmRNA A ®MCV4MCV® ®® 824.92023139.0%MCV42023COVID-192023598.42024202337.9% COVID-192023253.2 580.52023876.020232024(i)CDMO(ii) 20231231197.344.5%20241231109.5(i)82.9(ii)21.7 20231231353.40.3%20241231369.1 20231231294.534.0%20241231194.4 2023638.034.8%2024416.1(i)(ii)COVID-19COVID-19(iii)III 2023123156.82024123181.9(i)70.5(ii)2023123142.4COVID-19202412311.7 2023123156.32024123122.236.2 202412312.5202311.5 20231231295.820241231114.0 20231231111.820241231180.1III 20231231350.720241231280.5 20231231636.920241231737.6 (1)1A2024123172.0 20231231297.520241231113.72024 20231231239.82024123122.7 20231231104.02024123162.520241231 20231231866.827.1%20241231632.3(i)(ii) 20231231112.82024123175.1COVID-19 202312312,047.024.0%202412311,556.5 202412314,282.5202312315,180.81,556.51,183.11,542.9 202412311,772.0202312312,591.8892.2632.3247.5 20241231892.2202312311,394.91,098.5202312311,065.7MCV4 202412311,181.9202412310.70%2.91%10186 2,244.7662.9 202433ª Vara Civel de Maringa/PRBelcher Farmaceutica Ltda.Belcher2021COVID-19167197 BelcherBelcher20241231 20241231 20241231129.220231231317.959.4% 2024123120241231158.920231231166.9 1231 10.22023123111.220241231 (i)(ii)2024123150.0364.97.28507.771712 202412318.14%20231231 20242220242212 Xuefeng YU19636Yu20092009YuYu198571988619986(McGill)Yu30Yu1998-Sanofi Pasteur Limited-Yu19961998IBEX Technologies Inc.20244IBTYuAerasAeras Global TB VaccineFoundationAd5-EBOVAd5-nCoVYu10Yu Shou Bai CHAO196282018ChaoChao1982719857199210Chao30ChaoGMP2011ISPEChaoChaoCOVID-19ChaoChaoCOVID-19COVID-19 王 靖19801220212021202020212017202120201274320192020A+H 李 志 成19575202420241202412CSL Behring Asia Pacific Limited20222024201520222012201520062011Cephalon Inc.199720058Merck1996Abbott Laboratories Taiwan Limited19801995 2025Stratation Consultants Limited2024Cognitact Limited2022TE Healthcare Advisory Pte Ltd20202022212620152023CSL Behring Asia Pacific Limited2013201520122015 19801119869200610 桂 水 發19651201920186881582018202320182024201320186008202019688588198919931994199719982001200120110395860095820042012201220172017201820182024600835198962004919984 劉 建 忠1964320192012201620151989200320032011Sanofi S.A.1989619983 張 耀 樑195910202423019861020151202012 20232552202415482021ADAG 20202024212620182020201320182011201320102011200920102006 1982619838 肖 治19789202422019620242201668827730017120162021002930 邵 忠 琦 博 士196212201120211995200120022007IBEXTechnologies Inc.20244IBT20012002BioMarin Pharmaceutical Inc.20072011(Sanofi Pasteur Limited)19938(Concordia University) 孫 暢19911120241120196201632019560116220151220146 朱 濤19732200912024220091199571998620034(University ofPittsburgh)200410(Carnegie Mellon University)20042005Integrated Genomics Inc.20062008Ad5-EBOVCOVID-19COVID-19PBPVPCV13i Dongxu QIU19601Qiu2009120242Qiu2009120211QiuQiu1982719871219891119914(University of Konstanz)1992519931(University of Montreal)Qiu200010(University of Western Ontario)QiuQiu19931998Biomira, Inc.19992000Altarex Inc.20002002ARIUS Research Inc.20032005MDS Capital2006200920072011ChinaBioLLCQiuQiuPCV13PPV23AHQiuIII 崔 進19873202192018201920162017201820182021201520162012201520096201112 崔 進1987320193 趙 明 璟1977220193VistraCorporate Services (